136 related articles for article (PubMed ID: 9404479)
1. [Molecular abnormalities and clonality in myelodysplastic syndromes].
Fenaux P; Preudhomme C
Pathol Biol (Paris); 1997 Sep; 45(7):556-60. PubMed ID: 9404479
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic aspects of myelodysplastic syndromes.
Bartram CR
Hematol Oncol Clin North Am; 1992 Jun; 6(3):557-70. PubMed ID: 1613006
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndromes: from morphology to molecular biology. Part II. The molecular genetics of myelodysplasia.
Stephenson J; Mufti GJ; Yoshida Y
Int J Hematol; 1993 Apr; 57(2):99-112. PubMed ID: 8494999
[TBL] [Abstract][Full Text] [Related]
4. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
[TBL] [Abstract][Full Text] [Related]
5. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
6. NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
Fidler C; Watkins F; Bowen DT; Littlewood TJ; Wainscoat JS; Boultwood J
Haematologica; 2004 Jul; 89(7):865-6. PubMed ID: 15257941
[TBL] [Abstract][Full Text] [Related]
7. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
[TBL] [Abstract][Full Text] [Related]
8. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
Venkatraj VS; Gaidano G; Auerbach AD
Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
[TBL] [Abstract][Full Text] [Related]
9. [Cytogenetics of myelodysplastic syndromes].
Laï JL; Fenaux P
Pathol Biol (Paris); 1997 Sep; 45(7):550-5. PubMed ID: 9404478
[TBL] [Abstract][Full Text] [Related]
10. Lack of TP53 and FMS gene mutations in children with myelodysplastic syndrome.
Jekic B; Novakovic I; Lukovic L; Kuzmanovic M; Popovic B; Milasin J; Bunjevacki G; Damnjanovic T; Cvjeticanin S; Bunjevacki V
Cancer Genet Cytogenet; 2006 Apr; 166(2):163-5. PubMed ID: 16631474
[TBL] [Abstract][Full Text] [Related]
11. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
Bock O
Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608
[TBL] [Abstract][Full Text] [Related]
12. [Abnormalities of the expression of cytokines and their receptors in myelodysplastic syndromes].
Fontenay-Roupie M; Dreyfus F
Pathol Biol (Paris); 1997 Sep; 45(7):569-72. PubMed ID: 9404481
[TBL] [Abstract][Full Text] [Related]
13. Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome.
Misawa S; Horiike S; Kaneko H; Kashima K
Leukemia; 1997 Apr; 11 Suppl 3():533-5. PubMed ID: 9209448
[TBL] [Abstract][Full Text] [Related]
14. [Studies on chromosome aberrations and dyshemopoiesis in myelodysplastic syndromes].
Jiang Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Oct; 12(5):341-7. PubMed ID: 2151690
[TBL] [Abstract][Full Text] [Related]
15. The myelodysplastic syndromes.
Masey JA
Br J Biomed Sci; 1997 Mar; 54(1):65-70. PubMed ID: 9167309
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.
van der Straaten HM; van Biezen A; Brand R; Schattenberg AV; Egeler RM; Barge RM; Cornelissen JJ; Schouten HC; Ossenkoppele GJ; Verdonck LF;
Haematologica; 2005 Oct; 90(10):1339-45. PubMed ID: 16219570
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics of myelodysplastic syndromes.
Mecucci C; La Starza R
Forum (Genova); 1999; 9(1):4-13. PubMed ID: 10101207
[TBL] [Abstract][Full Text] [Related]
18. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.
Niemeyer CM; Kratz CP
Br J Haematol; 2008 Mar; 140(6):610-24. PubMed ID: 18302710
[TBL] [Abstract][Full Text] [Related]
19. Submicroscopic deletions in 5q- associated malignancies.
Crescenzi B; La Starza R; Romoli S; Beacci D; Matteucci C; Barba G; Aventin A; Marynen P; Ciolli S; Nozzoli C; Martelli MF; Mecucci C
Haematologica; 2004 Mar; 89(3):281-5. PubMed ID: 15020265
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications.
Panani AD; Roussos C
Cancer Lett; 2006 Apr; 235(2):177-90. PubMed ID: 15935553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
